Antonio Wolff, MD, will moderate a Wednesday afternoon session on questions that will inform clinical trial design and guide treatment decisions.

San Antonio Breast Cancer Symposium® Co-Directors Carlos Arteaga, MD, and Virginia Kaklamani, MD, share a message for the thousands of attendees joining the SABCS® in person and virtually this week.

Plan your Tuesday schedule and don’t miss notable items on the program, including concurrent Special Sessions and Educational Sessions that address hot topics in breast cancer.

Laleh Amiri-Kordestani, MD, and Eric Winer, MD, will moderate a Tuesday afternoon special session on new drug approvals, featuring insights from oncology experts at the U.S. Food and Drug Administration.

Mirat Shah, MD, will serve as one of the moderators for a Tuesday afternoon session that will reinforce the need for dosage and regimen optimization in breast cancer drug development and clinical trial design.